Manulife (Manufacturers Life Insurance)’s Protara Therapeutics TARA Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio TARA Stock Details TARA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$70.6K	Buy	13,548 +2,464	+22%	+$14.6K	﹤0.01%	2685
2025 Q4	$59.1K	Buy	+11,084	New	+$61.6K	﹤0.01%	2789
2017 Q3	–	Sell	-12	Closed	-$1K	–	4332
2017 Q2	$1K	Sell	12 -1	-8%	-$56	﹤0.01%	4254
2017 Q1	$1K	Hold	13	–	–	﹤0.01%	4077
2016 Q4	$1K	Hold	13	–	–	﹤0.01%	4225
2016 Q3	$5K	Hold	13	–	–	﹤0.01%	3889
2016 Q2	$4K	Sell	13 -39	-75%	-$11.7K	﹤0.01%	3872
2016 Q1	$16K	Buy	52 +13	+33%	+$4.19K	﹤0.01%	3543
2015 Q4	$24	Hold	39	–	–	﹤0.01%	3396
2015 Q3	$22	Buy	+39	New	+$24.2K	﹤0.01%	3435

Other funds holding TARA

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

IHAM

Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s TARA Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Protara Therapeutics (TARA) stake by 22% in Q1 2026, buying an estimated $14.6K and bringing the position to 13,548 shares worth $70.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2685.

Manulife (Manufacturers Life Insurance) first reported a position in TARA in Q3 2015 and has held it in 10 quarters since. 114 funds tracked by Wall St. Rank hold TARA as of Q1 2026.

Manulife (Manufacturers Life Insurance) held 13,548 shares of Protara Therapeutics worth $70.6K as of Q1 2026.
Manulife (Manufacturers Life Insurance) bought 2,464 Protara Therapeutics shares in Q1 2026, an estimated $14.6K.
Protara Therapeutics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2685 holding.
Manulife (Manufacturers Life Insurance) first reported a position in Protara Therapeutics in Q3 2015 and has held it in 10 quarters since.
114 funds tracked by Wall St. Rank held Protara Therapeutics as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.